Avivagen Inc. VIV.V Stock
Avivagen Inc. Price Chart
Avivagen Inc. VIV.V Financial and Trading Overview
| Avivagen Inc. stock price | 0.0050 CAD |
| Previous Close | 0.02 CAD |
| Open | 0.02 CAD |
| Bid | 0.02 CAD x 0 |
| Ask | 0.02 CAD x 0 |
| Day's Range | 0.02 - 0.02 CAD |
| 52 Week Range | 0.01 - 0.2 CAD |
| Volume | 3K CAD |
| Avg. Volume | 88.53K CAD |
| Market Cap | 1.17M CAD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.38 CAD |
VIV.V Valuation Measures
| Enterprise Value | 7.92M CAD |
| Trailing P/E | N/A |
| Forward P/E | -1.5 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.611254 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 10.944 |
| Enterprise Value/EBITDA | -2.015 |
Trading Information
Avivagen Inc. Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -90.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.2 CAD |
| 52 Week Low | 0.01 CAD |
| 50-Day Moving Average | 0.03 CAD |
| 200-Day Moving Average | 0.08 CAD |
VIV.V Share Statistics
| Avg. Volume (3 month) | 88.53K CAD |
| Avg. Daily Volume (10-Days) | 109.71K CAD |
| Shares Outstanding | 77.69M |
| Float | 76.27M |
| Short Ratio | 0.07 |
| % Held by Insiders | 1.11% |
| % Held by Institutions | 0% |
| Shares Short | 7.08K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.010% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | October 31, 2022 |
| Most Recent Quarter (mrq) | April 30, 2023 |
| Next Fiscal Year End | October 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -547.58% |
| Gross Margin | 41.96% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -148.30% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 723.3K CAD |
| Revenue Per Share (ttm) | 0.01 CAD |
| Quarterly Revenue Growth (yoy) | -12.19% |
| Gross Profit (ttm) | 400.3K CAD |
| EBITDA | -3929382 CAD |
| Net Income Avi to Common (ttm) | -5608436 CAD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 17.19K CAD |
| Total Cash Per Share (mrq) | 0 CAD |
| Total Debt (mrq) | 6.77M CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.036 |
| Book Value Per Share (mrq) | -0.107 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1953590 CAD |
| Levered Free Cash Flow (ttm) | -995128 CAD |
Profile of Avivagen Inc.
| Country | Canada |
| State | ON |
| City | Ottawa |
| Address | 100 Sussex Drive |
| ZIP | K1A 0R6 |
| Phone | N/A |
| Website | https://www.avivagen.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.
Q&A For Avivagen Inc. Stock
What is a current VIV.V stock price?
Avivagen Inc. VIV.V stock price today per share is 0.0050 CAD.
How to purchase Avivagen Inc. stock?
You can buy VIV.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Avivagen Inc.?
The stock symbol or ticker of Avivagen Inc. is VIV.V.
Which industry does the Avivagen Inc. company belong to?
The Avivagen Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Avivagen Inc. have in circulation?
The max supply of Avivagen Inc. shares is 77.69M.
What is Avivagen Inc. Price to Earnings Ratio (PE Ratio)?
Avivagen Inc. PE Ratio is now.
What was Avivagen Inc. earnings per share over the trailing 12 months (TTM)?
Avivagen Inc. EPS is -0.06 CAD over the trailing 12 months.
Which sector does the Avivagen Inc. company belong to?
The Avivagen Inc. sector is Healthcare.